Evaluation of Acute Post-thrombectomy Complications for Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

361 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-15

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective study to assess the incidence of acute complications after thrombectomy for stoke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research in the computerized medical file of patients admitted to intensive care unit (ICU) in the last 5 years for a stroke.

Searching for acute complications during the ICU stay. Looking for hemorrhagic, acute renal failure, hemodynamic support, neurologic degradation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Complication Stroke, Acute Stroke Hemorrhagic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thrombectomy for stroke

Patients who have had thrombectomy for acute stroke.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 year old
* ICU admitted patient for stroke and received thrombectomy

Exclusion Criteria

* missing data

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pierre Goffin

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre Goffin, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

MontLegia Hospital, Groupe Santé CHC, Liège, Belgium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MontLegia Hospital

Liège, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00014

Identifier Type: -

Identifier Source: org_study_id